CHN1 mouse monoclonal antibody, clone OTI2G6 (formerly 2G6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Products
CHN1 mouse monoclonal antibody, clone OTI2G6 (formerly 2G6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CHN1 mouse monoclonal antibody, clone OTI1C9 (formerly 1C9)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CHN1 mouse monoclonal antibody, clone OTI2D10 (formerly 2D10)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
CHN1 mouse monoclonal antibody, clone OTI2D10 (formerly 2D10)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
CHN1 mouse monoclonal antibody, clone OTI1C9 (formerly 1C9)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CHN1 (Myc-DDK-tagged)-Human chimerin (chimaerin) 1 (CHN1), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
CHN1 (Myc-DDK-tagged)-Human chimerin (chimaerin) 1 (CHN1), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
CHN1 (Myc-DDK tagged) - Homo sapiens chimerin 1 (CHN1), transcript variant 3
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
CHN1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
CHN1 (tGFP-tagged) - Human chimerin (chimaerin) 1 (CHN1), transcript variant 1
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
CHN1 (tGFP-tagged) - Human chimerin (chimaerin) 1 (CHN1), transcript variant 2
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
CHN1 (untagged)-Human chimerin (chimaerin) 1 (CHN1), transcript variant 2
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-AC |
CHN1 (untagged)-Human chimerin (chimaerin) 1 (CHN1), transcript variant 1
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL5 |
